Xtant Medical Reports 3Q17 Revenue
Xtant Medical posted 3Q17 revenue of US $19.8MM, -14.3% vs. 3Q16, with YTD revenue of $63.3MM, -3.4% vs. the prior year. Nov 28, 2017
Regentis Biomaterials Launches Phase III Pivotal Trial of GelrinC
Regentis Biomaterials commenced first surgeries in its Phase III pivotal clinical trial of GelrinC in the treatment of focal knee cartilage defects. Nov 28, 2017
Medicrea Gains FDA Clearance for 3D-Printed Ti Interbody
Medicrea received FDA 510(k) clearance to market IB3D™ 3D-printed interbody devices, and introduced its AdapTEK™ in-house additive manufacturing technology. Nov 27, 2017
Life Spine Launches SIMPACT TRI-FIN Sacroiliac Joint Fixation Screws
Life Spine commenced limited launch of the SIMPACT™ TRI-FIN sacroiliac joint fixation screw. Nov 21, 2017
Highmark Issues Exclusive Coverage Policy for coflex Interlaminar Stabilization
Highmark is reported to be the first and only private payor to issue exclusive positive coverage for Paradigm Spine’s coflex® Interlaminar Stabilization®. Nov 20, 2017
Titan Spine’s First Endoskeleton Interbody Fusion Cases in Australia
Titan Spine entered the Australian market with its Endoskeleton® interbody fusion devices and surface technology. Nov 16, 2017
DJO Global 3Q17 Revenue
DJO Global posted 3Q17 revenue of US $290.9MM, +1.3% vs. 3Q16, and YTD revenue of $873.9MM, +1.7% vs. the prior year. Nov 16, 2017
PeerWell Launches App for Outpatient Joint Recon Recovery
PeerWell is launching the PreHab to ReHab program for patients undergoing hip or knee replacement in outpatient centers. Nov 16, 2017
Alphatec Spine Posts 3Q17 Revenue
Alphatec Spine posted 3Q17 revenue of US $23.1MM, -13.5% vs. 3Q16, and YTD revenue of $75.5MM, -4.6% vs. the prior year. Nov 15, 2017
Globus Medical Announces 3Q17 Revenue
Globus Medical reported 3Q17 revenue of US $151.7MM, +11.9% vs. 3Q16, and YTD revenue of $459.9MM, +11.5% vs. the prior year. Nov 15, 2017
